Overview of the progress of the KSUMC Clinical Practice Guidelines Adaptation and Implementation Program in the Department of Pediatrics which is the most active department in the program
EBP is a systemic interconnecting of scientifically generated evidence with the tacit knowledge of the expert practitioner to achieve a change in a particular practice for the benefit of a well-defined client/ patient group.
EBP is a systemic interconnecting of scientifically generated evidence with the tacit knowledge of the expert practitioner to achieve a change in a particular practice for the benefit of a well-defined client/ patient group.
Palliative Care Interdisciplinary Team model for Clinical Ethics Consultation...Andi Chatburn, DO, MA
Interactive workshop presentation exploring the Palliative Care model for Interdisciplinary Team consultation in an application for Clinical Ethics Consultation. Presented at the American Society for Bioethics and Humanities national conference in San Diego, October 17, 2014.
evidence based practice is best for the people working with patients
ebp should be used by the heath care provider.
ebp based upon clinical experties
best research evidence
patient preference and values
Innovations in Medical Education are needed to align it with 21st Century needs and aspirations. Globally efforts are under way since the release of Lancet Commission report in Dec-2010 on Transforming Health Professions in the 21st Century
37 slide presentation involving learning objectives, introduction, components of CBME, teaching-learning-assessment-challenges in CBME, MCI UG curriculum and its future implicability
Retraining of motor control basing on understanding of normal movement & analysis of motor dysfunction.
Emphasis of MRP is on practice of specific activities, the training of cognitive control over muscles & movt. Components of activities & conscious elimination of unnecessary muscle activity.
In rehabilitation programme involve – real life activities included.
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
Palliative Care Interdisciplinary Team model for Clinical Ethics Consultation...Andi Chatburn, DO, MA
Interactive workshop presentation exploring the Palliative Care model for Interdisciplinary Team consultation in an application for Clinical Ethics Consultation. Presented at the American Society for Bioethics and Humanities national conference in San Diego, October 17, 2014.
evidence based practice is best for the people working with patients
ebp should be used by the heath care provider.
ebp based upon clinical experties
best research evidence
patient preference and values
Innovations in Medical Education are needed to align it with 21st Century needs and aspirations. Globally efforts are under way since the release of Lancet Commission report in Dec-2010 on Transforming Health Professions in the 21st Century
37 slide presentation involving learning objectives, introduction, components of CBME, teaching-learning-assessment-challenges in CBME, MCI UG curriculum and its future implicability
Retraining of motor control basing on understanding of normal movement & analysis of motor dysfunction.
Emphasis of MRP is on practice of specific activities, the training of cognitive control over muscles & movt. Components of activities & conscious elimination of unnecessary muscle activity.
In rehabilitation programme involve – real life activities included.
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
This session was conducted as a part of the 6th Resident Professional Development Course titled "Evidence-Based Medicine" in 9th SEPT 2015 at College of Medicine, King Saud University
The Adapted ADAPTE approach to CPG adaptation proposed by the Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Egypt.
An oral presentation conducted by Prof. Tarek Omar during the national initiative of the Pediatrics Department, Armed Forces College of Medicine, themed; 'Towards National Guidelines' that was launched in 2018 and started by Pediatrics CPGs
EVIDENCE-BASED CPGs FOR HEMATOLOGY - ONCOLOGY UNIT, KING SAUD UNIVERSITY HOPSITALS
Saudi Arabia, Riyadh
King Saud University Hospitals
CPGs Committee
Quality Management Dept
CPGs Program
By YASSER SAMI AMER
An introduction on Evidence-Based Clinical Practice Guidelines in Health Care Organizations
Brief on Alexandria Center for EBCPGs in Alexandria University Hospitals, Egypt
By Dr. Yasser Sami Abdel Dayem Amer, MBBCh, MS 2013
Special Thanks to
Prof Dr Mahmoud Elzalabany
Prof Dr Tarek Omar
Prof Dr Nabil Dowidar
Prof Dr Afaf Gaber
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Cancer Institute NSW
The commonly understood model of shift to shift nursing handover does not apply to most ambulatory day treatment units. Nonetheless, ‘handover’ of patient clinical information remains quintessential to safe clinical practice. Of considerable interest is how EMR may aid the transfer of patient clinical information in these circumstances and address the question: does this facilitate improved patient care?
Reducing stillbirth and early neonatal death, pop up uni, 11am, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
An awareness session conducted for physicians of the psyhciatry department at KSUMC on Monday 25/11/2019 at King Khalid University Hospital, Riyadh, KSA
Presented as part of the Capacity Building in Policy Briefs Development Workshop conducted by Research Chair for Evidence-Based Health Care and Knowledge Translation
In collaboration with World Health Organization, Regional Office for the Eastern Mediterranean in King Saud University 2019.
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
CPG adaptation project for Childhood CSE.
(Dissemination and Implementation Phase)
Training session for Pediatrics resident at King Khalid University Hospital, King Saud University Medical City
Illustration on how the CPGs Adaptation Program has helped in quality improvement through compliance with national and international accreditation standards.
What is the difference between development and adaptation of clinical practice guidelines? This was presented by Dr. Yasser Amer during the 2nd Regional Workshop for CPG adaptation, Tunis, Tunisia May 24-26 2016
Link:
https://www.facebook.com/media/set/?set=a.481589005298936.1073741852.215244758600030&type=1&l=67dff997c7
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
ADAPTE Phase Two: ADAPTATION PHASE
Search and Screen Module
Presented by Dr. Yasser S. Amer during the 2nd Regional Workshop for CPG Adaptation in Tunis, Tunisia May 24-26, 2016
A collaborative between INA Sante, WHO-EMRO, King Saud University
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
A 15-minutes oral presentation that was given in ISQua's 32nd International Conference, Doha, October 2015 by Dr. Yasser Amer under the track: "Quality and Safety in Developing Countries"
The Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument evaluates the process of practice guideline development and the quality of reporting.
The original AGREE Instrument has been updated and methodologically refined. The AGREE II is now the new international tool for the assessment of practice guidelines. The AGREE II is both valid and reliable and comprises 23 items organized into the original 6 quality domains.
http://www.agreetrust.org/
An overview on priorities in health research was a part of a course for research methodology delivered in King Saud University College of Medicine August 2015
CPG Implementation is “the phase in the guideline lifecycle in which strategies, systems, and tools are created to operationalize the knowledge and recommendations set forth by the guideline developers”, or is “ the part of the guideline lifecycle in which systems are introduced to influence clinicians’ behavior toward guideline adherence”. Implementation barriers and facilitators are defined as factors that actually prevent or enhance, respectively, changes in clinical behavior.
The concept of CPG Implementability was first defined by Shiffman as a set of characteristics that can predict the ease of and/ or obstacles to CPG implementation. Implementability is an abstract concept related to several factors, including intrinsic factors that are specific to the CPG itself and under control of the CPG development group) and extrinsic factors that are often specific to the intended healthcare settings and context of implementation. Also a validated tool for appraisal of implementability of CPGs named “GuideLine Implementability Appraisal (GLIA)” was developed by Schiffman RN et al, from the Yale Center for Medical Informatics, Yale School of Medicine and School of Nursing at Yale University in USA in 2005. A second version was released including a free online platform (electronic or e-GLIA). The GLIA considers only the intrinsic factors in the appraisal and is organized into two parts; part 1, including the global dimension with seven questions that examine the entire CPG document as a whole, and part 2, including the other nine dimensions with twenty-four questions that appraise each recommendation individually regarding the identified nine intrinsic factors or dimensions of implementability. The nine dimensions are decidability, executability, effect on the process of care, presentation and formatting, measurable outcomes, apparent validity, novelty/ innovation, flexibility, and computability.
An introductory overview of the basic concepts of Healthcare Quality, a starter for beginners.
Prepared in 2014 for the new staff of the Quality Management Department in King Saud University Medical City in Riyadh as a part of their capacity building plan.
Acknowledgments:
*Dr. Magdy Gamal Yousef, MBBCh, MS, CPHQ - for his contribution in the scientific content
**Ms. Maram Baksh, MS, CPHQ - for the design of the full HCQ capacity building plan in KSUMC
APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION (AGREE) II Instrument: Assessment of the Quality of Clinical Practice Guidelines.
A training workshop presented to the healthcare professionals (i.e. physicians, nurses, pharmacists, technicians,...etc.) of King Khalid University Hospital, King Saud University in Riyadh, Saudi Arabia in August 2014.
I present my highest gratitude to all of my professors and colleagues who have and still inspire me.
Namely, Prof. Mahmoud El-Zalabany, Prof. Tarek Omar, Prof. Nabil Dowidar and Prof. Afaf Ibrahim (Alexandria Univ., EG), Prof. Abdelhamid Attia (Cairo Univ., EG), Prof. Lubna Al-Ansary, Dr. Hayfaa Wahbi, Dr. Rasmieh Alzeidan (King Saud Univ., KSA), Prof. David Sackett and Dr. Melissa Brouwers (McMaster Univ., CAN)
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Department in King Saud University Medical City
1. King Saud University Medical City
Clinical Practice Guidelines Program
PEDIATRICS Departmental Quality Team (DQT)
PEDIATRICS CPGs Departmental Committee
CPGs Implementation & Auditing
Jumada'I 1436 - March 2015KSUMC-Wide CPGs Committee – Pediatrics Departmental CPGs subCommittee
1
Presented By
Dr. Yasser Sami Amer
MBBCh, MS Pedia, MS HC Inf, CPHQ
Coordinator/ Advisor, KSUMC-Wide CPG Steering Committee
Coordinator, Pediatrics DQT
Coordinator, R & D, QMD
Member, eSiHi CPOE Physicians Team
Member, G-I-N AWG, IWG, PMWG
3. Evidence-Based Medicine (EBM) Movement: Not new!
865–925 Al-Razi (Rhazes)
1st need for experiments, comparisons in clinical studies
981–1037 Ibn Sina (Avicenna)
test effect of drugs on humans not animals only
1987 David M. Eddy, MD, PhD
‘EB’ in EBCPGs, policies in workshops, manual
1992 Gordon Guyatt, MD
‘EBM’ term in JAMA
1996 David Sackett, MD
‘EBM’ definition in BMJ
Jumada'I 1436 - March 2015
"Colofón-Libro de Medicina de Razi" by Muhammad ibn Zakariya al-Razi - Transferred from http://en.wikipedia.org/wiki/Image:Colophon-Razi's_Book_of_medicine_for_Mansur.jpg. Licensed under
Public Domain via Wikimedia Commons - http://commons.wikimedia.org/wiki/File:Colof%C3%B3n-Libro_de_Medicina_de_Razi.jpg#mediaviewer/File:Colof%C3%B3n-Libro_de_Medicina_de_Razi.jpg
3
7. Definition: (old)
“Systematically developed statements to
assist practitioner and patient decisions
about appropriate health care for specific
clinical circumstances” (IOM 1990)
Clinical Practice Guidelines (CPGs)
7
8. CPGs New Definition
CPGs are “Statements that include
Recommendations intended to
optimize patient care that are
informed by a Systematic Review of
evidence and an assessment of the
benefits and harms of alternative care
options”.
Committee on Standards for Developing
Trustworthy CPGs (IOM-AHRQ 2011)
11. Clinical Practice Guidelines (CPGs) Program
of King Saud University Hospitals/ Medical City
KSUHs Taskforce Responsible Staff from:
Clinical Practice Guidelines Steering Committee;
Quality Management Department;
Clinical Departments (CPGs Departmental
subCommittees);
Shaikh Abdullah Bahamdan Research Chair for
Evidence-Based Health Care and Knowledge
Translation;
Top Management & Leadership of College of Medicine
and University Hospitals (Future KSU Medical City)
09 JAN 2014Antibiotic Prophylaxis in Surgery 11
12. 21 KSUMC CPGs Subcommittees
1. Department of Pediatrics
2. Department of Critical Care
3. Department of Psychiatry
4. Primary Care/ Family Medicine Clinics
(Ambulatory Care Services)
5. Department of Pharmacy
6. Department of Emergency Medicine
7. Department of Medicine
8. Department of Orthopedic Surgery
9. Department of Otorhinolaryngology
10. Department of Ophthalmology
11. Department of Cardiac Sciences/ KFCC
(Cardiology – Cardiac Surgery)
12. Department of Surgery
13. Department of Obstetrics &
Gynecology
14. Department of Dermatology
15. Department of Anesthesiology
16. Department of Laboratory Medicine &
Pathology
17. Department of Nursing
18. Department of Radiology
19. Health Education Center
20. Department of Rehabilitation Medicine
21. Department of Infection Control
12
New (in progress)
1. Department of Occupational Health & Safety
2. Department of Clinical Nutrition
15. Adaptation of CPGs
Is the systematic approach to the endorsement
and/or modification of a guideline(s) produced in
one cultural and organizational setting for
application in a different context. Adaptation
may be used as an alternative to de novo
guideline development, e.g., for customizing (an)
existing guideline(s) to suit the local context.
http://www.adapte.org/
http://www.g-i-n.net/
17. 3/5/2015
6
10
5
22222
1111
00000000000
6
22
1
2
0
111
0
2
0
11111
00
0
2
4
6
8
10
12
KSUMC CPGS IN ALL DEPARTMENTS APPROVED BY CGC
(FEB 2015 - JUMADA'I 1436)
# CPGs approved # CPGs in progress
*Pooling specialties
(reviewers)
DEM actively participated in
adaptation or review of CPGs from
other department (i.e. PED & MED)
PED the most active department in terms of adaptation,
implementation and auditing of CPGs (6 finalized, 6 in progress, 4
fully implemented, 2 with outcome results of auditing
40. CPG implementation strategies
Dissemination Process (print/ e-/website)
Local Clinical Champions.
Awareness raising/ training activities.
Networking and linking with existing
projects (e.g. Dept. Clinical Rounds, CPD/CME activities, Accreditation, etc..).
Patients as champions for change.
Regular M & E (Auditing) (The ‘living’ CPG concept!).
Thursday,
March 5, 2015
CPGs Implementability & Implementation - Dr. Yasser Amer 40
41. Adapt/ design CPG implementation tools
available at the point of care (* MR)
TYPES
1. Clinical Algorithm.
2. Integrated Care/ Clinical Pathways*.
3. Protocol and/ or Policy & Procedure
4. Chart Documentation/ checklists/ forms (e.g. Physician Order Sets* later
CPOE/eSIHI).
5. Quick Reference Guides/ Physician Guides & Pocket Guide/Reference Cards (at-a-
glance summary of key recommendations 5 or 1-2 pages).
6. Clinical audit criteria (tool)
7. Quality (outcome/performance) measures
8. Slide Presentation.
9. Wall Poster.
10. Patient Resources/ Information (health education guides).
11. Foreign language Translation (Non-English, Non-Arabic).
12. Implementation Tool Kits (collections of tools and/or strategies).
13. Staff Training/ Competency Material. Thursday,
March 5, 2015
CPGs Implementability & Implemen.tation - Dr. Yasser Amer
41
42. How to read the KSUMC CPGs full
documents? TABLE OF CONTENTS
Preface by authors
Acknowledgments
Abbreviations
Overview material
Introduction
Statement of intent
Scope & Purpose (Health Questions PIPOH)
Recommendations (Key & details)
External review & consensus
Plan for scheduled review & update
List of funding sources
Adaptation process methodology
Implementation considerations & Tools
References
42
43. Health/ Clinical/ Key Questions
Patient (& disease characteristics)
Intervention(s)
Professionals (Target users)
Outcomes (purpose of the CPGs)
Healthcare settings (& context)
19th March
2013
EBCPGs: Dr. Yasser Sami Amer 43
CPG Scope: PIPOH Model
49. Who is the contact person for EBCPGs in your
department?
Head, Departmental CPG subCommittee:
Dr. Sarar Mohamed
Members, Departmental CPG subCommittee (#?)
Head, Department Quality Team:
Dr. Mohamed El-Faki
Coordinator, KSUMC-Wide CPG Steering Committee:
Dr. Yasser Amer
Medical Secretary, KSUMC-Wide CPG Steering Committee:
Ms. Dorothy Villena, Ms. Sheila Rivera
3/5/2015 49
50. Results of the Outcome measurement of CPGs
implementation in Pediatrics: DKA
50
51. Results of the Outcome measurement of CPGs implementation in
Pediatrics: Severe sepsis/ septic shock in PICU
51
52. Examples of KSUMC Clinical
Practice Guideline Adaptation
& Implementation Projects
presented and/or published in
International Conferences AND
National Events
53. The adapted CPG for Management of
Diabetic Ketoacidosis in children from the
Department of Pediatrics
Presented by Dr. Sara Mohamed, Associate Professor &
Consultant of Pediatric Endocrinology & Metabolism and Head
of Pediatrics CPGs Subcommittee presented in three
international conferences:-
1. American Endocrine Society Conference, San Francisco,
USA. CPG: challenges and opportunities in 14/6/2013 ENDO
2013 15-18/6.
2. European society of pediatric endocrinology conference,
Milan, Italy in 20/9/2013 – DKA Guidelines: Saudi
Experience.
54. Featured Poster Presentation Number: FP32-6 Poster Board Number: MON-282
https://endo.confex.com/endo/2013endo/webprogram/Paper6468.html
A
DISCLOSURES: Nothing to disclose
Development and implementation of Clinical Practice Guidelines
in Pediatric Endocrinology: Challenges and opportunities
Sarar Mohamed, Hala Omer, Nasir Al Jurryaan, Amir Babiker, Hessah Al-Otibi, Rana Hasanato, Shaikh Iqbal
,Mohamed Elfaki Osman, Nouf Alkhemis, Ali Abdo, Abdulrahman Al-Nemri
Department of Pediatrics & Chemistry, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
55.
56. 56
The Endocrine Society’s 97th Meeting & EXPO (ENDO 2015) March 5 – 8 2015,
San Diego, USA By Dr. Sarar Mohamed
57. Thank YOU all for listening
57
Contact Information: Dr. Yasser Sami Amer
Emails: yasser3amer@yahoo.com; yamer@ksu.edu.sa
Mobile: +966-50-857-7246, +966-51-525-2439
Office: +966-11-46-91341